DCM
CLBT icon

DGS Capital Management’s Cellebrite CLBT Stock Holding History

DGS Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Sell
16,527
-433
-3% -$6.53K 0.04% 509
2025
Q4 		$306K Buy
16,960
+110
+0.7% +$1.98K 0.05% 324
2025
Q3 		$312K Sell
16,850
-216
-1% -$3.39K 0.06% 278
2025
Q2 		$273K Buy
17,066
+267
+2% +$4.76K 0.06% 254
2025
Q1 		$326K Hold
16,799
– – 0.09% 213
2024
Q4 		$370K Sell
16,799
-369
-2% -$7.1K 0.09% 189
2024
Q3 		$289K Sell
17,168
-119
-0.7% -$1.77K 0.08% 222
2024
Q2 		$207K Sell
17,287
-665
-4% -$7.43K 0.06% 261
2024
Q1 		$199K Buy
17,952
+45
+0.3% +$459 0.06% 269
2023
Q4 		$155K Sell
17,907
-8,708
-33% -$67.7K 0.06% 233
2023
Q3 		$204K Sell
26,615
-818
-3% -$6.14K 0.1% 206
2023
Q2 		$198K Buy
27,433
+1,862
+7% +$10.9K 0.1% 214
2023
Q1 		$156K Buy
+25,571
New +$139K 0.09% 202
2022
Q3 		– Sell
-12,636
Closed -$64K – 209
2022
Q2 		$64K Buy
+12,636
New +$65.7K 0.05% 187

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DGS Capital Management's CLBT Position: Q1 2026 in Review

DGS Capital Management reduced its Cellebrite (CLBT) stake by 2.6% in Q1 2026, selling an estimated $6.53K and leaving 16,527 shares worth $228K. The position accounts for 0.04% of the portfolio, ranked #509.

DGS Capital Management first reported a position in CLBT in Q2 2022 and has held it in 14 quarters since. The position peaked at $370K in Q4 2024. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • DGS Capital Management held 16,527 shares of Cellebrite worth $228K as of Q1 2026.
  • DGS Capital Management sold 433 Cellebrite shares in Q1 2026, an estimated $6.53K.
  • Cellebrite made up 0.04% of DGS Capital Management's portfolio in Q1 2026, its #509 holding.
  • DGS Capital Management first reported a position in Cellebrite in Q2 2022 and has held it in 14 quarters since.
  • DGS Capital Management's Cellebrite position peaked at $370K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.